Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk</title><author><name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B" last="Spurdle">Amanda B. Spurdle</name><affiliation><nlm:aff id="A1">Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia</nlm:aff></affiliation><affiliation><nlm:aff id="A2">School of Medicine, University of Queensland, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Whiley, Phillip J" sort="Whiley, Phillip J" uniqKey="Whiley P" first="Phillip J" last="Whiley">Phillip J. Whiley</name><affiliation><nlm:aff id="A1">Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Thompson, Bryony" sort="Thompson, Bryony" uniqKey="Thompson B" first="Bryony" last="Thompson">Bryony Thompson</name><affiliation><nlm:aff id="A1">Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia</nlm:aff></affiliation><affiliation><nlm:aff id="A2">School of Medicine, University of Queensland, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Feng, Bingjian" sort="Feng, Bingjian" uniqKey="Feng B" first="Bingjian" last="Feng">Bingjian Feng</name><affiliation><nlm:aff id="A3">Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA</nlm:aff></affiliation></author><author><name sortKey="Healey, Sue" sort="Healey, Sue" uniqKey="Healey S" first="Sue" last="Healey">Sue Healey</name><affiliation><nlm:aff id="A1">Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Brown, Melissa A" sort="Brown, Melissa A" uniqKey="Brown M" first="Melissa A" last="Brown">Melissa A. Brown</name><affiliation><nlm:aff id="A4">School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Pettigrew, Christopher" sort="Pettigrew, Christopher" uniqKey="Pettigrew C" first="Christopher" last="Pettigrew">Christopher Pettigrew</name><affiliation><nlm:aff id="A4">School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Van Asperen, Christi J" sort="Van Asperen, Christi J" uniqKey="Van Asperen C" first="Christi J" last="Van Asperen">Christi J. Van Asperen</name><affiliation><nlm:aff id="A6">Department of Clinical Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Ausems, Margreet G E M" sort="Ausems, Margreet G E M" uniqKey="Ausems M" first="Margreet G E M" last="Ausems">Margreet G E M. Ausems</name><affiliation><nlm:aff id="A7">Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Kattentidt Mouravieva, Anna A" sort="Kattentidt Mouravieva, Anna A" uniqKey="Kattentidt Mouravieva A" first="Anna A" last="Kattentidt-Mouravieva">Anna A. Kattentidt-Mouravieva</name><affiliation><nlm:aff id="A8">Department of Clinical Genetics, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Van Den Ouweland, Ans M W" sort="Van Den Ouweland, Ans M W" uniqKey="Van Den Ouweland A" first="Ans M W" last="Van Den Ouweland">Ans M W. Van Den Ouweland</name><affiliation><nlm:aff id="A8">Department of Clinical Genetics, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Lindblom, Annika" sort="Lindblom, Annika" uniqKey="Lindblom A" first="Annika" last="Lindblom">Annika Lindblom</name><affiliation><nlm:aff id="A11">Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden</nlm:aff></affiliation></author><author><name sortKey="Pigg, Maritta H" sort="Pigg, Maritta H" uniqKey="Pigg M" first="Maritta H" last="Pigg">Maritta H. Pigg</name><affiliation><nlm:aff id="A12">Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden</nlm:aff></affiliation></author><author><name sortKey="Schmutzler, Rita K" sort="Schmutzler, Rita K" uniqKey="Schmutzler R" first="Rita K" last="Schmutzler">Rita K. Schmutzler</name><affiliation><nlm:aff id="A13">Department of Gynaecology and Obstetrics, Centre of Familial Breast and Ovarian Cancer and Centre for Molecular Medicine Cologne, University of Cologne, Cologne, Germany</nlm:aff></affiliation></author><author><name sortKey="Engel, Christoph" sort="Engel, Christoph" uniqKey="Engel C" first="Christoph" last="Engel">Christoph Engel</name><affiliation><nlm:aff id="A14">Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany</nlm:aff></affiliation></author><author><name sortKey="Meindl, Alfons" sort="Meindl, Alfons" uniqKey="Meindl A" first="Alfons" last="Meindl">Alfons Meindl</name><affiliation><nlm:aff id="A15">Department of Gynaecology and Obstetrics, Technical University of Munich, Munich, Germany</nlm:aff></affiliation></author><author><name sortKey="Caputo, Sandrine" sort="Caputo, Sandrine" uniqKey="Caputo S" first="Sandrine" last="Caputo">Sandrine Caputo</name><affiliation><nlm:aff id="A16">Institut Curie, Hôpital René Huguenin, Service d'Oncogénétique, U735 INSERM, Saint-Cloud, France</nlm:aff></affiliation></author><author><name sortKey="Sinilnikova, Olga M" sort="Sinilnikova, Olga M" uniqKey="Sinilnikova O" first="Olga M" last="Sinilnikova">Olga M. Sinilnikova</name><affiliation><nlm:aff id="A17">Unite Mixte de Genetique Constitutionnelle des Cancers Frequents, Hospices Civils de Lyon/Centre Leon Berard, Lyon, France</nlm:aff></affiliation><affiliation><nlm:aff id="A18">INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France</nlm:aff></affiliation></author><author><name sortKey="Lidereau, Rosette" sort="Lidereau, Rosette" uniqKey="Lidereau R" first="Rosette" last="Lidereau">Rosette Lidereau</name><affiliation><nlm:aff id="A16">Institut Curie, Hôpital René Huguenin, Service d'Oncogénétique, U735 INSERM, Saint-Cloud, France</nlm:aff></affiliation></author><author><name sortKey="Couch, Fergus J" sort="Couch, Fergus J" uniqKey="Couch F" first="Fergus J" last="Couch">Fergus J. Couch</name><affiliation><nlm:aff id="A20">Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA</nlm:aff></affiliation></author><author><name sortKey="Guidugli, Lucia" sort="Guidugli, Lucia" uniqKey="Guidugli L" first="Lucia" last="Guidugli">Lucia Guidugli</name><affiliation><nlm:aff id="A20">Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA</nlm:aff></affiliation></author><author><name sortKey="Hansen, Thomas Van Overeem" sort="Hansen, Thomas Van Overeem" uniqKey="Hansen T" first="Thomas Van Overeem" last="Hansen">Thomas Van Overeem Hansen</name><affiliation><nlm:aff id="A21">Center for Genomic Medicine, Rigshospitalet, Copenhagen University hospital, Copenhagen, Denmark</nlm:aff></affiliation></author><author><name sortKey="Thomassen, Mads" sort="Thomassen, Mads" uniqKey="Thomassen M" first="Mads" last="Thomassen">Mads Thomassen</name><affiliation><nlm:aff id="A22">Department of Clinical Genetics, Odense University Hospital, Odense, Denmark</nlm:aff></affiliation></author><author><name sortKey="Eccles, Diana M" sort="Eccles, Diana M" uniqKey="Eccles D" first="Diana M" last="Eccles">Diana M. Eccles</name><affiliation><nlm:aff id="A23">Faculty of Medicine, University of Southampton, Southampton University Hospital NHS Trust MP824, Southampton, UK</nlm:aff></affiliation></author><author><name sortKey="Tucker, Kathy" sort="Tucker, Kathy" uniqKey="Tucker K" first="Kathy" last="Tucker">Kathy Tucker</name><affiliation><nlm:aff id="A24">Hereditary Cancer Clinic, Prince of Wales Hospital, Randwick, Australia</nlm:aff></affiliation></author><author><name sortKey="Benitez, Javier" sort="Benitez, Javier" uniqKey="Benitez J" first="Javier" last="Benitez">Javier Benitez</name><affiliation><nlm:aff id="A25">Spanish National Cancer Centre, Madrid, Spain</nlm:aff></affiliation></author><author><name sortKey="Domchek, Susan M" sort="Domchek, Susan M" uniqKey="Domchek S" first="Susan M" last="Domchek">Susan M. Domchek</name><affiliation><nlm:aff id="A26">Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA</nlm:aff></affiliation></author><author><name sortKey="Toland, Amanda E" sort="Toland, Amanda E" uniqKey="Toland A" first="Amanda E" last="Toland">Amanda E. Toland</name><affiliation><nlm:aff id="A27">Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, OSU Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA</nlm:aff></affiliation></author><author><name sortKey="Van Rensburg, Elizabeth J" sort="Van Rensburg, Elizabeth J" uniqKey="Van Rensburg E" first="Elizabeth J" last="Van Rensburg">Elizabeth J. Van Rensburg</name><affiliation><nlm:aff id="A28">Department of Genetics, University of Pretoria, Hatfield, South Africa</nlm:aff></affiliation></author><author><name sortKey="Wappenschmidt, Barbara" sort="Wappenschmidt, Barbara" uniqKey="Wappenschmidt B" first="Barbara" last="Wappenschmidt">Barbara Wappenschmidt</name><affiliation><nlm:aff id="A13">Department of Gynaecology and Obstetrics, Centre of Familial Breast and Ovarian Cancer and Centre for Molecular Medicine Cologne, University of Cologne, Cologne, Germany</nlm:aff></affiliation></author><author><name sortKey="Borg, Ke" sort="Borg, Ke" uniqKey="Borg " first=" Ke" last="Borg"> Ke Borg</name><affiliation><nlm:aff id="A29">Åke Borg, Department of Oncology, Lund University, Lund, Sweden</nlm:aff></affiliation></author><author><name sortKey="Vreeswijk, Maaike P G" sort="Vreeswijk, Maaike P G" uniqKey="Vreeswijk M" first="Maaike P G" last="Vreeswijk">Maaike P G. Vreeswijk</name><affiliation><nlm:aff id="A30">Department of Human Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Goldgar, David E" sort="Goldgar, David E" uniqKey="Goldgar D" first="David E" last="Goldgar">David E. Goldgar</name><affiliation><nlm:aff id="A3">Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA</nlm:aff></affiliation><affiliation><nlm:aff id="A31">Huntsman Cancer Institute, Salt Lake City, Utah, USA</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">22889855</idno><idno type="pmc">3810416</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810416</idno><idno type="RBID">PMC:3810416</idno><idno type="doi">10.1136/jmedgenet-2012-101037</idno><date when="2012">2012</date><idno type="wicri:Area/Pmc/Corpus">001F18</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001F18</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk</title><author><name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B" last="Spurdle">Amanda B. Spurdle</name><affiliation><nlm:aff id="A1">Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia</nlm:aff></affiliation><affiliation><nlm:aff id="A2">School of Medicine, University of Queensland, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Whiley, Phillip J" sort="Whiley, Phillip J" uniqKey="Whiley P" first="Phillip J" last="Whiley">Phillip J. Whiley</name><affiliation><nlm:aff id="A1">Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Thompson, Bryony" sort="Thompson, Bryony" uniqKey="Thompson B" first="Bryony" last="Thompson">Bryony Thompson</name><affiliation><nlm:aff id="A1">Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia</nlm:aff></affiliation><affiliation><nlm:aff id="A2">School of Medicine, University of Queensland, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Feng, Bingjian" sort="Feng, Bingjian" uniqKey="Feng B" first="Bingjian" last="Feng">Bingjian Feng</name><affiliation><nlm:aff id="A3">Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA</nlm:aff></affiliation></author><author><name sortKey="Healey, Sue" sort="Healey, Sue" uniqKey="Healey S" first="Sue" last="Healey">Sue Healey</name><affiliation><nlm:aff id="A1">Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Brown, Melissa A" sort="Brown, Melissa A" uniqKey="Brown M" first="Melissa A" last="Brown">Melissa A. Brown</name><affiliation><nlm:aff id="A4">School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Pettigrew, Christopher" sort="Pettigrew, Christopher" uniqKey="Pettigrew C" first="Christopher" last="Pettigrew">Christopher Pettigrew</name><affiliation><nlm:aff id="A4">School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia</nlm:aff></affiliation></author><author><name sortKey="Van Asperen, Christi J" sort="Van Asperen, Christi J" uniqKey="Van Asperen C" first="Christi J" last="Van Asperen">Christi J. Van Asperen</name><affiliation><nlm:aff id="A6">Department of Clinical Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Ausems, Margreet G E M" sort="Ausems, Margreet G E M" uniqKey="Ausems M" first="Margreet G E M" last="Ausems">Margreet G E M. Ausems</name><affiliation><nlm:aff id="A7">Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Kattentidt Mouravieva, Anna A" sort="Kattentidt Mouravieva, Anna A" uniqKey="Kattentidt Mouravieva A" first="Anna A" last="Kattentidt-Mouravieva">Anna A. Kattentidt-Mouravieva</name><affiliation><nlm:aff id="A8">Department of Clinical Genetics, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Van Den Ouweland, Ans M W" sort="Van Den Ouweland, Ans M W" uniqKey="Van Den Ouweland A" first="Ans M W" last="Van Den Ouweland">Ans M W. Van Den Ouweland</name><affiliation><nlm:aff id="A8">Department of Clinical Genetics, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Lindblom, Annika" sort="Lindblom, Annika" uniqKey="Lindblom A" first="Annika" last="Lindblom">Annika Lindblom</name><affiliation><nlm:aff id="A11">Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden</nlm:aff></affiliation></author><author><name sortKey="Pigg, Maritta H" sort="Pigg, Maritta H" uniqKey="Pigg M" first="Maritta H" last="Pigg">Maritta H. Pigg</name><affiliation><nlm:aff id="A12">Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden</nlm:aff></affiliation></author><author><name sortKey="Schmutzler, Rita K" sort="Schmutzler, Rita K" uniqKey="Schmutzler R" first="Rita K" last="Schmutzler">Rita K. Schmutzler</name><affiliation><nlm:aff id="A13">Department of Gynaecology and Obstetrics, Centre of Familial Breast and Ovarian Cancer and Centre for Molecular Medicine Cologne, University of Cologne, Cologne, Germany</nlm:aff></affiliation></author><author><name sortKey="Engel, Christoph" sort="Engel, Christoph" uniqKey="Engel C" first="Christoph" last="Engel">Christoph Engel</name><affiliation><nlm:aff id="A14">Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany</nlm:aff></affiliation></author><author><name sortKey="Meindl, Alfons" sort="Meindl, Alfons" uniqKey="Meindl A" first="Alfons" last="Meindl">Alfons Meindl</name><affiliation><nlm:aff id="A15">Department of Gynaecology and Obstetrics, Technical University of Munich, Munich, Germany</nlm:aff></affiliation></author><author><name sortKey="Caputo, Sandrine" sort="Caputo, Sandrine" uniqKey="Caputo S" first="Sandrine" last="Caputo">Sandrine Caputo</name><affiliation><nlm:aff id="A16">Institut Curie, Hôpital René Huguenin, Service d'Oncogénétique, U735 INSERM, Saint-Cloud, France</nlm:aff></affiliation></author><author><name sortKey="Sinilnikova, Olga M" sort="Sinilnikova, Olga M" uniqKey="Sinilnikova O" first="Olga M" last="Sinilnikova">Olga M. Sinilnikova</name><affiliation><nlm:aff id="A17">Unite Mixte de Genetique Constitutionnelle des Cancers Frequents, Hospices Civils de Lyon/Centre Leon Berard, Lyon, France</nlm:aff></affiliation><affiliation><nlm:aff id="A18">INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France</nlm:aff></affiliation></author><author><name sortKey="Lidereau, Rosette" sort="Lidereau, Rosette" uniqKey="Lidereau R" first="Rosette" last="Lidereau">Rosette Lidereau</name><affiliation><nlm:aff id="A16">Institut Curie, Hôpital René Huguenin, Service d'Oncogénétique, U735 INSERM, Saint-Cloud, France</nlm:aff></affiliation></author><author><name sortKey="Couch, Fergus J" sort="Couch, Fergus J" uniqKey="Couch F" first="Fergus J" last="Couch">Fergus J. Couch</name><affiliation><nlm:aff id="A20">Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA</nlm:aff></affiliation></author><author><name sortKey="Guidugli, Lucia" sort="Guidugli, Lucia" uniqKey="Guidugli L" first="Lucia" last="Guidugli">Lucia Guidugli</name><affiliation><nlm:aff id="A20">Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA</nlm:aff></affiliation></author><author><name sortKey="Hansen, Thomas Van Overeem" sort="Hansen, Thomas Van Overeem" uniqKey="Hansen T" first="Thomas Van Overeem" last="Hansen">Thomas Van Overeem Hansen</name><affiliation><nlm:aff id="A21">Center for Genomic Medicine, Rigshospitalet, Copenhagen University hospital, Copenhagen, Denmark</nlm:aff></affiliation></author><author><name sortKey="Thomassen, Mads" sort="Thomassen, Mads" uniqKey="Thomassen M" first="Mads" last="Thomassen">Mads Thomassen</name><affiliation><nlm:aff id="A22">Department of Clinical Genetics, Odense University Hospital, Odense, Denmark</nlm:aff></affiliation></author><author><name sortKey="Eccles, Diana M" sort="Eccles, Diana M" uniqKey="Eccles D" first="Diana M" last="Eccles">Diana M. Eccles</name><affiliation><nlm:aff id="A23">Faculty of Medicine, University of Southampton, Southampton University Hospital NHS Trust MP824, Southampton, UK</nlm:aff></affiliation></author><author><name sortKey="Tucker, Kathy" sort="Tucker, Kathy" uniqKey="Tucker K" first="Kathy" last="Tucker">Kathy Tucker</name><affiliation><nlm:aff id="A24">Hereditary Cancer Clinic, Prince of Wales Hospital, Randwick, Australia</nlm:aff></affiliation></author><author><name sortKey="Benitez, Javier" sort="Benitez, Javier" uniqKey="Benitez J" first="Javier" last="Benitez">Javier Benitez</name><affiliation><nlm:aff id="A25">Spanish National Cancer Centre, Madrid, Spain</nlm:aff></affiliation></author><author><name sortKey="Domchek, Susan M" sort="Domchek, Susan M" uniqKey="Domchek S" first="Susan M" last="Domchek">Susan M. Domchek</name><affiliation><nlm:aff id="A26">Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA</nlm:aff></affiliation></author><author><name sortKey="Toland, Amanda E" sort="Toland, Amanda E" uniqKey="Toland A" first="Amanda E" last="Toland">Amanda E. Toland</name><affiliation><nlm:aff id="A27">Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, OSU Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA</nlm:aff></affiliation></author><author><name sortKey="Van Rensburg, Elizabeth J" sort="Van Rensburg, Elizabeth J" uniqKey="Van Rensburg E" first="Elizabeth J" last="Van Rensburg">Elizabeth J. Van Rensburg</name><affiliation><nlm:aff id="A28">Department of Genetics, University of Pretoria, Hatfield, South Africa</nlm:aff></affiliation></author><author><name sortKey="Wappenschmidt, Barbara" sort="Wappenschmidt, Barbara" uniqKey="Wappenschmidt B" first="Barbara" last="Wappenschmidt">Barbara Wappenschmidt</name><affiliation><nlm:aff id="A13">Department of Gynaecology and Obstetrics, Centre of Familial Breast and Ovarian Cancer and Centre for Molecular Medicine Cologne, University of Cologne, Cologne, Germany</nlm:aff></affiliation></author><author><name sortKey="Borg, Ke" sort="Borg, Ke" uniqKey="Borg " first=" Ke" last="Borg"> Ke Borg</name><affiliation><nlm:aff id="A29">Åke Borg, Department of Oncology, Lund University, Lund, Sweden</nlm:aff></affiliation></author><author><name sortKey="Vreeswijk, Maaike P G" sort="Vreeswijk, Maaike P G" uniqKey="Vreeswijk M" first="Maaike P G" last="Vreeswijk">Maaike P G. Vreeswijk</name><affiliation><nlm:aff id="A30">Department of Human Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Goldgar, David E" sort="Goldgar, David E" uniqKey="Goldgar D" first="David E" last="Goldgar">David E. Goldgar</name><affiliation><nlm:aff id="A3">Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA</nlm:aff></affiliation><affiliation><nlm:aff id="A31">Huntsman Cancer Institute, Salt Lake City, Utah, USA</nlm:aff></affiliation></author></analytic><series><title level="j">Journal of medical genetics</title><idno type="ISSN">0022-2593</idno><idno type="eISSN">1468-6244</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title><p id="P2">Clinical classification of rare sequence changes identified in the breast cancer susceptibility genes <italic>BRCA1</italic> and <italic>BRCA2</italic> is essential for appropriate genetic counselling of individuals carrying these variants. We previously showed that variant BRCA1 c.5096G>A p. Arg1699Gln in the BRCA1 transcriptional transactivation domain demonstrated equivocal results from a series of functional assays, and proposed that this variant may confer low to moderate risk of cancer.</p></sec><sec id="S2"><title>Methods</title><p id="P3">Measures of genetic risk (report of family history, segregation) were assessed for 68 <italic>BRCA1</italic> c.5096G>A p.Arg1699Gln (R1699Q) families recruited through family cancer clinics, comparing results with 34 families carrying the previously classified pathogenic <italic>BRCA1</italic> c.5095C>T p.Arg1699Trp (R1699W) mutation at the same residue, and to 243 breast cancer families with no <italic>BRCA1</italic> pathogenic mutation (BRCA-X).</p></sec><sec id="S3"><title>Results</title><p id="P4">Comparison of <italic>BRCA1</italic> carrier prediction scores of probands using the BOADICEA risk prediction tool revealed that <italic>BRCA1</italic> c.5096G>A p.Arg1699Gln variant carriers had family histories that were less ‘<italic>BRCA1</italic>-like’ than <italic>BRCA1</italic> c.5095C>T p.Arg1699Trp mutation carriers (p<0.00001), but more ‘<italic>BRCA1</italic>-like’ than BRCA-X families (p=0.0004). Further, modified segregation analysis of the subset of 30 families with additional genotyping showed that <italic>BRCA1</italic> c.5096G >A p. Arg1699Gln had reduced penetrance compared with the average truncating <italic>BRCA1</italic> mutation penetrance (p=0.0002), with estimated cumulative risks to age 70 of breast or ovarian cancer of 24%.</p></sec><sec id="S4"><title>Conclusions</title><p id="P5">Our results provide substantial evidence that the <italic>BRCA1</italic> c.5096G>A p.Arg1699Gln (R1699Q) variant, demonstrating ambiguous functional deficiency across multiple assays, is associated with intermediate risk of breast and ovarian cancer, highlighting challenges for risk modelling and clinical management of patients of this and other potential moderate-risk variants.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">2985087R</journal-id><journal-id journal-id-type="pubmed-jr-id">4945</journal-id><journal-id journal-id-type="nlm-ta">J Med Genet</journal-id><journal-id journal-id-type="iso-abbrev">J. Med. Genet.</journal-id><journal-title-group><journal-title>Journal of medical genetics</journal-title></journal-title-group><issn pub-type="ppub">0022-2593</issn><issn pub-type="epub">1468-6244</issn></journal-meta><article-meta><article-id pub-id-type="pmid">22889855</article-id><article-id pub-id-type="pmc">3810416</article-id><article-id pub-id-type="doi">10.1136/jmedgenet-2012-101037</article-id><article-id pub-id-type="manuscript">NIHMS498935</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Spurdle</surname><given-names>Amanda B</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Whiley</surname><given-names>Phillip J</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Thompson</surname><given-names>Bryony</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Bingjian</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Healey</surname><given-names>Sue</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Melissa A</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Pettigrew</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>kConFab</surname><given-names></given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Van Asperen</surname><given-names>Christi J</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Ausems</surname><given-names>Margreet G E M</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Kattentidt-Mouravieva</surname><given-names>Anna A</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>van den Ouweland</surname><given-names>Ans M W</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><collab>Dutch Belgium UV Consortium</collab><xref ref-type="author-notes" rid="FN1">9</xref><xref ref-type="aff" rid="A10">10</xref></contrib><contrib contrib-type="author"><name><surname>Lindblom</surname><given-names>Annika</given-names></name><xref ref-type="aff" rid="A11">11</xref></contrib><contrib contrib-type="author"><name><surname>Pigg</surname><given-names>Maritta H</given-names></name><xref ref-type="aff" rid="A12">12</xref></contrib><contrib contrib-type="author"><name><surname>Schmutzler</surname><given-names>Rita K</given-names></name><xref ref-type="aff" rid="A13">13</xref></contrib><contrib contrib-type="author"><name><surname>Engel</surname><given-names>Christoph</given-names></name><xref ref-type="aff" rid="A14">14</xref></contrib><contrib contrib-type="author"><name><surname>Meindl</surname><given-names>Alfons</given-names></name><xref ref-type="aff" rid="A15">15</xref></contrib><contrib contrib-type="author"><collab>German Consortium of Hereditary Breast and Ovarian Cancer</collab><xref ref-type="author-notes" rid="FN1">9</xref><xref ref-type="aff" rid="A13">13</xref></contrib><contrib contrib-type="author"><name><surname>Caputo</surname><given-names>Sandrine</given-names></name><xref ref-type="aff" rid="A16">16</xref></contrib><contrib contrib-type="author"><name><surname>Sinilnikova</surname><given-names>Olga M</given-names></name><xref ref-type="aff" rid="A17">17</xref><xref ref-type="aff" rid="A18">18</xref></contrib><contrib contrib-type="author"><name><surname>Lidereau</surname><given-names>Rosette</given-names></name><xref ref-type="aff" rid="A16">16</xref></contrib><contrib contrib-type="author"><collab>French COVAR group collaborators</collab><xref ref-type="aff" rid="A19">19</xref></contrib><contrib contrib-type="author"><name><surname>Couch</surname><given-names>Fergus J</given-names></name><xref ref-type="aff" rid="A20">20</xref></contrib><contrib contrib-type="author"><name><surname>Guidugli</surname><given-names>Lucia</given-names></name><xref ref-type="aff" rid="A20">20</xref></contrib><contrib contrib-type="author"><name><surname>Hansen</surname><given-names>Thomas van Overeem</given-names></name><xref ref-type="aff" rid="A21">21</xref></contrib><contrib contrib-type="author"><name><surname>Thomassen</surname><given-names>Mads</given-names></name><xref ref-type="aff" rid="A22">22</xref></contrib><contrib contrib-type="author"><name><surname>Eccles</surname><given-names>Diana M</given-names></name><xref ref-type="aff" rid="A23">23</xref></contrib><contrib contrib-type="author"><name><surname>Tucker</surname><given-names>Kathy</given-names></name><xref ref-type="aff" rid="A24">24</xref></contrib><contrib contrib-type="author"><name><surname>Benitez</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="A25">25</xref></contrib><contrib contrib-type="author"><name><surname>Domchek</surname><given-names>Susan M</given-names></name><xref ref-type="aff" rid="A26">26</xref></contrib><contrib contrib-type="author"><name><surname>Toland</surname><given-names>Amanda E</given-names></name><xref ref-type="aff" rid="A27">27</xref></contrib><contrib contrib-type="author"><name><surname>Van Rensburg</surname><given-names>Elizabeth J</given-names></name><xref ref-type="aff" rid="A28">28</xref></contrib><contrib contrib-type="author"><name><surname>Wappenschmidt</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="A13">13</xref></contrib><contrib contrib-type="author"><name><surname>Borg</surname><given-names>Åke</given-names></name><xref ref-type="aff" rid="A29">29</xref></contrib><contrib contrib-type="author"><name><surname>Vreeswijk</surname><given-names>Maaike P G</given-names></name><xref ref-type="aff" rid="A30">30</xref></contrib><contrib contrib-type="author"><name><surname>Goldgar</surname><given-names>David E</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A31">31</xref><on-behalf-of>on behalf of the ENIGMA Consortium</on-behalf-of><xref ref-type="author-notes" rid="FN1">9</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia</aff><aff id="A2"><label>2</label>School of Medicine, University of Queensland, Brisbane, Queensland, Australia</aff><aff id="A3"><label>3</label>Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA</aff><aff id="A4"><label>4</label>School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia</aff><aff id="A5"><label>5</label>Peter MacCallum Cancer Institute, Melbourne, Victoria 3000, Australia</aff><aff id="A6"><label>6</label>Department of Clinical Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands</aff><aff id="A7"><label>7</label>Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands</aff><aff id="A8"><label>8</label>Department of Clinical Genetics, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands</aff><aff id="A10"><label>10</label>Dutch Belgium UV Consortium, Co-ordinator F.B. Hogervorst, The Netherlands Cancer Institute, Amsterdam, The Netherlands</aff><aff id="A11"><label>11</label>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden</aff><aff id="A12"><label>12</label>Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden</aff><aff id="A13"><label>13</label>Department of Gynaecology and Obstetrics, Centre of Familial Breast and Ovarian Cancer and Centre for Molecular Medicine Cologne, University of Cologne, Cologne, Germany</aff><aff id="A14"><label>14</label>Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany</aff><aff id="A15"><label>15</label>Department of Gynaecology and Obstetrics, Technical University of Munich, Munich, Germany</aff><aff id="A16"><label>16</label>Institut Curie, Hôpital René Huguenin, Service d'Oncogénétique, U735 INSERM, Saint-Cloud, France</aff><aff id="A17"><label>17</label>Unite Mixte de Genetique Constitutionnelle des Cancers Frequents, Hospices Civils de Lyon/Centre Leon Berard, Lyon, France</aff><aff id="A18"><label>18</label>INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France</aff><aff id="A19"><label>19</label>French COVAR group collaborators co-ordinator Rosette Lidereau, Institut Curie, Hôpital René Huguenin, Service d'Oncogénétique, U735 INSERM—Saint-Cloud, France</aff><aff id="A20"><label>20</label>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA</aff><aff id="A21"><label>21</label>Center for Genomic Medicine, Rigshospitalet, Copenhagen University hospital, Copenhagen, Denmark</aff><aff id="A22"><label>22</label>Department of Clinical Genetics, Odense University Hospital, Odense, Denmark</aff><aff id="A23"><label>23</label>Faculty of Medicine, University of Southampton, Southampton University Hospital NHS Trust MP824, Southampton, UK</aff><aff id="A24"><label>24</label>Hereditary Cancer Clinic, Prince of Wales Hospital, Randwick, Australia</aff><aff id="A25"><label>25</label>Spanish National Cancer Centre, Madrid, Spain</aff><aff id="A26"><label>26</label>Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA</aff><aff id="A27"><label>27</label>Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, OSU Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA</aff><aff id="A28"><label>28</label>Department of Genetics, University of Pretoria, Hatfield, South Africa</aff><aff id="A29"><label>29</label>Åke Borg, Department of Oncology, Lund University, Lund, Sweden</aff><aff id="A30"><label>30</label>Department of Human Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands</aff><aff id="A31"><label>31</label>Huntsman Cancer Institute, Salt Lake City, Utah, USA</aff><author-notes><corresp id="cor1"><bold>Correspondence to</bold>: Dr Amanda B Spurdle, Division of Genetics and Population Health, Queensland Institute of Medical Research, 300 Herston Road, Herston, QLD 4006, Australia; <email>Amanda.Spurdle@qimr.edu.au</email>; Professor David E Goldgar, Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA; <email>david.goldgar@hsc.utah.edu</email></corresp><fn id="FN1"><label>9</label><p id="P1">See <xref ref-type="supplementary-material" rid="SD1">Appendix</xref> for full list of ENIGMA collaborators contributing to this study, operating within and outside of country consortia</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>10</day><month>9</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2012</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>10</month><year>2013</year></pub-date><volume>49</volume><issue>8</issue><elocation-id>10.1136/jmedgenet-2012-101037</elocation-id><abstract><sec id="S1"><title>Background</title><p id="P2">Clinical classification of rare sequence changes identified in the breast cancer susceptibility genes <italic>BRCA1</italic> and <italic>BRCA2</italic> is essential for appropriate genetic counselling of individuals carrying these variants. We previously showed that variant BRCA1 c.5096G>A p. Arg1699Gln in the BRCA1 transcriptional transactivation domain demonstrated equivocal results from a series of functional assays, and proposed that this variant may confer low to moderate risk of cancer.</p></sec><sec id="S2"><title>Methods</title><p id="P3">Measures of genetic risk (report of family history, segregation) were assessed for 68 <italic>BRCA1</italic> c.5096G>A p.Arg1699Gln (R1699Q) families recruited through family cancer clinics, comparing results with 34 families carrying the previously classified pathogenic <italic>BRCA1</italic> c.5095C>T p.Arg1699Trp (R1699W) mutation at the same residue, and to 243 breast cancer families with no <italic>BRCA1</italic> pathogenic mutation (BRCA-X).</p></sec><sec id="S3"><title>Results</title><p id="P4">Comparison of <italic>BRCA1</italic> carrier prediction scores of probands using the BOADICEA risk prediction tool revealed that <italic>BRCA1</italic> c.5096G>A p.Arg1699Gln variant carriers had family histories that were less ‘<italic>BRCA1</italic>-like’ than <italic>BRCA1</italic> c.5095C>T p.Arg1699Trp mutation carriers (p<0.00001), but more ‘<italic>BRCA1</italic>-like’ than BRCA-X families (p=0.0004). Further, modified segregation analysis of the subset of 30 families with additional genotyping showed that <italic>BRCA1</italic> c.5096G >A p. Arg1699Gln had reduced penetrance compared with the average truncating <italic>BRCA1</italic> mutation penetrance (p=0.0002), with estimated cumulative risks to age 70 of breast or ovarian cancer of 24%.</p></sec><sec id="S4"><title>Conclusions</title><p id="P5">Our results provide substantial evidence that the <italic>BRCA1</italic> c.5096G>A p.Arg1699Gln (R1699Q) variant, demonstrating ambiguous functional deficiency across multiple assays, is associated with intermediate risk of breast and ovarian cancer, highlighting challenges for risk modelling and clinical management of patients of this and other potential moderate-risk variants.</p></sec></abstract><funding-group><award-group><funding-source country="United States">National Cancer Institute : NCI</funding-source><award-id>R01 CA116167 || CA</award-id></award-group><award-group><funding-source country="United States">National Cancer Institute : NCI</funding-source><award-id>P50 CA116201 || CA</award-id></award-group></funding-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F18 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001F18 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.33. |  |